Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia

Clinical Oncology

Volumn 10, Issue 6, 1998, Pages 407-409

  Sims, E C ^a   Rogers, P B ^a   Besser, G M ^a   Plowman, P N ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Bisphosphonate; Hypocalcaemia

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; PAMIDRONIC ACID;

AGED; ARTICLE; BREAST METASTASIS; CASE REPORT; FEMALE; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; PRIORITY JOURNAL;

EID: 0032443140     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(98)80045-9     Document Type: Article

References (12)

1. Carlson HE, Casciato DA. Metabolic Complications. In: Casciato DA, Lowitz BB, editors. Manual of clinical oncology. 3rd ed. Boston MA: Little, Brown, 1995:456-9.
2. Fraser WD, Logue FC, O'Reilly DSJ, et al. The effects of aminohydroxyproline bisphosphonate (APD) on calcium, PTH 1-84 and nephrogenous cAMP in patients with hypercalcaemia of malignancy and Paget's disease of bone. Bone 1989;10:475.
3. Ritch P, Gucalp R, Wiernik P, et al. Pamidronate (APD) and etidronate sodium in hypercalcaemia of malignancy - preliminary report of a comparative multicentre trial. In: Rubens RD, editor. The management of bone metastases and hypercalcaemia by osteoclast inhibition: an International Symposium held during the 5th European Conference on Clinical Oncology (ECCO 5) London, Sep 1989. Toronto: Hogrefe and Huber, 1990:47-9.
4. Fleisch H. Bisphosphonates. Pharmacology and use in the treatment of tumour induced hypercalcaemia and metastatic bone disease. Drugs 1991;42:919-44.
5. Hall TG, Schaiff RAB. Update on the medical treatment of hypercalcaemia of malignancy. Clin Pharm 1993;12:117-25.
6. Purohit OP, Anthony C, Radstone CR, et al. High dose intravenous pamidronate for metastatic bone pain. Br J Cancer 1994;70:554-8.
7. Pederson-Bjergaard U, Mhyre J. Severe hypocalcaemia (corrected) after treatment with diphosphonate and aminoglycoside [letter]. BMJ 1990;302:791.
8. Mayordomo JI, Rivera F. Severe hypocalcaemia after treatment with oral clodronate and aminoglycoside [letter]. Ann Oncol 1993;4:432-3.
9. McIntyre E, Bruera E. Symptomatic hypocalcaemia after intravenous pamidronate. J Palliat Care 1996;12:46-7.
10. Varma N, Kerrigan GNW. Electrocardiographic Q-Tc prolongation associated with infusion of intravenous pamidronate disodium. Postgrad Med J 1993;69:497-8.
11. Purohit OP, Radstone CR, Anthony C, et al. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy. Br J Cancer 1995;72:1289-93.
12. Vinholes J, Guo CY, Purohit OP, et al. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcaemia of malignancy. J Clin Oncol 1997;15:131-8.